MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Adamis Pharmaceuticals Corp Company Profile (NASDAQ:ADMP)

Consensus Ratings for Adamis Pharmaceuticals Corp (NASDAQ:ADMP) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $17.00 (507.14% upside)

Analysts' Ratings History for Adamis Pharmaceuticals Corp (NASDAQ:ADMP)
Show:
DateFirmActionRatingPrice TargetActions
6/6/2016Maxim GroupReiterated RatingBuy$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/29/2015MizuhoInitiated CoverageBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/30/2014 forward)
Earnings History for Adamis Pharmaceuticals Corp (NASDAQ:ADMP)
No earnings announcements for this company have been tracked by MarketBeat.com

Earnings Estimates for Adamis Pharmaceuticals Corp (NASDAQ:ADMP)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Adamis Pharmaceuticals Corp (NASDAQ:ADMP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Adamis Pharmaceuticals Corp (NASDAQ:ADMP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/2/2016David J MarguglioVPSell700$9.00$6,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2016David J MarguglioSVPSell4,000$8.08$32,320.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2016David J MarguglioSVPSell4,860$10.00$48,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/4/2016David J MarguglioSVPSell4,860$9.17$44,566.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/3/2016David J MarguglioSVPSell1,140$9.00$10,260.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2016David J MarguglioSVPSell12,000$7.52$90,240.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2015Robert B RothermelDirectorBuy7,000$3.33$23,310.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/20/2015David J MarguglioSVPSell200$5.00$1,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2015David J MarguglioSVPSell2,200$5.01$11,022.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2015David J MarguglioSVPSell11,800$7.09$83,662.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015David J MarguglioSVPSell7,000$6.45$45,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/13/2015Ahmed Shayan Fazlur RahmanMajor ShareholderSell12,076$6.41$77,407.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2015Ahmed Shayan Fazlur RahmanMajor ShareholderSell38,000$6.40$243,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2015Ahmed Shayan Fazlur RahmanMajor ShareholderSell30,000$6.75$202,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2015David J MarguglioVPSell7,000$6.18$43,260.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/30/2014David J MarguglioSVPSell12,228$6.09$74,468.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/29/2014David J MarguglioVPSell772$6.00$4,632.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/12/2014David J MarguglioSVPSell4,000$5.18$20,720.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2014William C DenbyDirectorBuy2,500$5.06$12,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/29/2014Robert B RothermelDirectorBuy5,500$4.03$22,165.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2014David J MarguglioSVPSell4,000$5.56$22,240.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2013Ahmed Shayan Fazlur RahmanMajor ShareholderSell7,015$0.57$3,998.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2013Ahmed Shayan Fazlur RahmanMajor ShareholderSell40,000$0.56$22,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/2/2013Ahmed Shayan Fazlur RahmanMajor ShareholderSell67,960$0.57$38,737.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/30/2013Ahmed Shayan Fazlur RahmanMajor ShareholderSell10,328$0.56$5,783.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/26/2013Ahmed Shayan Fazlur RahmanMajor ShareholderSell95,000$0.56$53,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/23/2013Ahmed Shayan Fazlur RahmanMajor ShareholderSell141,224$0.57$80,497.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Adamis Pharmaceuticals Corp (NASDAQ:ADMP)
DateHeadline
06/29/16 02:16 PMShares Entering Oversold Area: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) - Press Telegraph
06/29/16 02:16 PMAdamis Pharmaceuticals Corporation (ADMP) Current Analyst Ratings - Fiscal Standard
06/28/16 02:32 PMCheck on Share Volatility: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) - Engelwood Daily
06/27/16 03:54 PMADAMIS PHARMACEUTICALS CORP Files SEC form 8-K/A, Financial Statements and Exhibits -
06/27/16 07:04 AMAdamis Pharmaceuticals Corporation (ADMP) Broker Price Targets For The Coming Week - Fiscal Standard
06/26/16 07:07 AMAdamis Pharmaceuticals Corporation (NASDAQ:ADMP) Short Interest Increased By 40.68% - Press Telegraph
06/24/16 07:32 PMAdamis Pharmaceuticals Corporation (ADMP) Updated Price Targets - FTSE News
06/24/16 02:19 PMStock in Oversold Area: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) - Press Telegraph
06/21/16 07:05 AMRecently Issued Stock Ratings For Adamis Pharmaceuticals Corporation (ADMP) - Fiscal Standard
06/15/16 02:19 PMFive9, Inc. (NASDAQ:FIVN) Increased 2.78%: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), Falconstor ... - KC Register
06/13/16 04:08 PMADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Other Events -
06/13/16 02:18 PMOversold Stocks: TransEnterix, Inc. (NYSEMKT:TRXC), Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), Qunar ... - KC Register
06/12/16 09:20 AM7 Biopharma Companies That Destroyed Shareholders Last Week -
06/10/16 02:19 PMTwo Stocks within Traders Limelight: Galena Biopharma, Inc. (NASDAQ:GALE) , Adamis Pharmaceuticals Corporation ... - Street Updates
06/08/16 02:31 PMAnalyst Opinions on: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), Flowers Foods, Inc. (NYSE:FLO) - Beacon Chronicle
06/07/16 10:42 AMThe Medicines Company (NASDAQ:MDCO) & Adamis Pharmaceuticals Corp (NASDAQ:ADMP) Hot Healthcare Stock's ... - Wall Street 24
06/06/16 07:55 PMAnalysts Weigh In On Two Falling Biotechs: Adamis Pharmaceuticals Corp (ADMP), Immunomedics, Inc. (IMMU) - Smarter Analyst
06/06/16 12:48 PMStocks gain traction as Yellen plays down weak jobs report - [at MarketWatch] - U.S. stocks are trading higher after paring gains slightly in the wake of comments from Federal Reserve Chairwoman Janet Yellen, who on Monday cautioned that investors shouldn’t read too much into Friday’s ...
06/06/16 12:08 PMMylan Gains From Adamis Pain -
06/06/16 11:53 AMAdamis Pharmaceuticals Corp (ADMP) Stock Crashes on CRL for Epinephrine - Bidness ETC
06/06/16 07:13 AMUPDATE 1-FDA rejects Adamis' emergency drug for severe allergic reaction - June 6 (Reuters) - Adamis Pharmaceuticals Corp said on Monday the U.S. Food and Drug Administration rejected its emergency treatment for acute anaphylaxis, a severe allergic reaction, for the second...
06/04/16 10:46 AMAdamis Pharmaceuticals Corporation (NASDAQ:ADMP), Exxon Mobil Corporation (NYSE:XOM), AT&T, Inc. (NYSE:T ... - KC Register
06/01/16 02:19 PMAdamis Pharmaceuticals Corporation (NASDAQ:ADMP) Short Interest Increased By 41.05% - HNN - Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Short Interest Increased By 41.05%HNNThe stock of Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) registered an increase of 41.05% in short interest. ADMP's total short interest was 377,300 shares in June as published by FINRA. Its up 41.05% from 267,500 shares, reported previously.and more »
06/01/16 10:41 AMAdamis Pharmaceuticals Corporation (ADMP) Do Brokers Advise Buy, Sell Or Hold? - Share Trading News - Adamis Pharmaceuticals Corporation (ADMP) Do Brokers Advise Buy, Sell Or Hold?Share Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Adamis Pharmaceuticals Corporation (ADMP). The latest reports which are currently in issue on Wednesday 1st of June state 0 analysts have a rating of “strong buy”, 0 ...Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Short Interest Increased By 41.05%HNNall 2 news articles »
05/31/16 04:05 PMADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
05/31/16 02:19 PMWeekly Biotech Report on upcoming FDA decision for Adamis Pharmaceuticals Corp (NASDAQ:ADMP) Epinephrine pre-filled syringe for anaphylaxis - This one is an already established scientificly. It’s a reformulation of epinephrine (adrenaline), which is the hormone administered when individuals suffer from anaphylaxis, as an immediate response therapy. Anaphylaxis is an allergic reaction that ...
05/29/16 10:46 AMAdamis Pharmaceuticals Corporation (NASDAQ:ADMP) Impact Score At 0 - RealistInvestor.com - Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Impact Score At 0RealistInvestor.comAlpha One explored various online articles released on Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), and it set a daily sentiment score of 0.458 on the company. The entity has an algorithm in place to know stock sentiment on the share after ...and more »
05/27/16 11:01 AMAdamis Pharmaceuticals Corporation (NASDAQ:ADMP) Sellers Increased By 41.05% Their Shorts - Wall Street Hints and News - Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Sellers Increased By 41.05% Their ShortsWall Street Hints and NewsThe stock of Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) registered an increase of 41.05% in short interest. ADMP's total short interest was 377,300 shares in May as published by FINRA. Its up 41.05% from 267,500 shares, reported previously.and more »
05/21/16 02:01 PMBroker Outlook For Adamis Pharmaceuticals Corporation (ADMP) - Share Trading News - Broker Outlook For Adamis Pharmaceuticals Corporation (ADMP)Share Trading NewsThe Company's product candidates for the treatment of asthma and chronic obstructive pulmonary disease (COPD) are APC-5000 DPI and APC-1000. The Company's other product candidates in its allergy and respiratory product pipeline include APC-1000, ...
05/21/16 02:01 PMRevenue Update on Adamis Pharmaceuticals Corp(NASDAQ:ADMP) - Trade Calls - Revenue Update on Adamis Pharmaceuticals Corp(NASDAQ:ADMP)Trade CallsAdamis Pharmaceuticals Corp(NASDAQ:ADMP) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during Pre-market on May 13, 2016. Company reported revenue of $0.00. Analysts estimated a revenue of $5.40M. Earnings ...Adamis Pharmaceuticals Corp (ADMP) Files Form 4 Insider Selling : David J. Marguglio Sells 4000 SharesMarket Digestall 4 news articles »
05/13/16 08:49 AMStocks Recent Trading Summary: Prestige Brand Holdings, Inc. (NYSE:PBH) , Adamis Pharmaceuticals Corporation ... - Street Updates - Stocks Recent Trading Summary: Prestige Brand Holdings, Inc. (NYSE:PBH) , Adamis Pharmaceuticals Corporation ...Street UpdatesIn the past trading session, Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) highlighted downward shift of -5.45% or -0.49 points to $8.50. The company traded a volume of 395.48 thousand shares over average volume of 127.76 thousand shares.and more »
05/13/16 08:49 AMAdamis Pharmaceuticals Corp (ADMP) Given Buy Rating at Maxim Group - Washington News Wire - Washington News WireAdamis Pharmaceuticals Corp (ADMP) Given Buy Rating at Maxim GroupWashington News WireAdamis Pharmaceuticals Corp (NASDAQ:ADMP)'s stock had its “buy” rating restated by research analysts at Maxim Group in a research note issued to investors on Tuesday, Analyst Ratings Network.com reports. In other news, SVP David J. Marguglio sold ...Adamis Pharmaceuticals Corp's (ADMP) Buy Rating Reaffirmed at Maxim GroupWeb Breaking NewsAdamis Pharmaceuticals (ADMP) Enters Epinephrine PFS Licensing Agreement with Allergan (AGN) UnitStreetInsider.comAdamis Pharmaceuticals Corporation (ADMP) Latest Broker CoverageRisers & FallersSeeking Alpha -B.O.D.Y Confidential -Street Registerall 14 news articles »
05/10/16 03:28 PMADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events -
05/10/16 05:46 AM6:46 am Adamis Pharma enters into license agreement with Watson Laboratories, a subsidiary of Allergan (AGN) to commercialize Adamis' Epinephrine Pre-filled Syringe product candidate for anaphylaxis -
05/09/16 04:19 PMWhy Is Adamis Pharmaceuticals Corporation (ADMP) So Hot Right Now? -
05/09/16 08:22 AMAdamis Pharmaceuticals Corporation (ADMP) Broker Price Targets For The Coming Week - Share Trading News - Web Breaking NewsAdamis Pharmaceuticals Corporation (ADMP) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Adamis Pharmaceuticals Corporation (ADMP). The latest reports which are currently in issue on Sunday 8th of May state 0 analysts have a rating of “strong buy”, 0 ...Share Performance Review : Adamis Pharmaceuticals Corporation (NASDAQ:ADMP)The PostAdamis Pharmaceuticals Corp (ADMP) SVP David J. Marguglio Sells 4860 SharesWeb Breaking NewsIs Adamis Pharmaceuticals Corp (NASDAQ:ADMP) Stock a Sell after David Marguglio's Insider Deal?B.O.D.Y ConfidentialRisers & Fallersall 5 news articles »
05/05/16 08:34 AMLatest Analyst Ratings For Adamis Pharmaceuticals Corporation (ADMP) - Share Trading News - Latest Analyst Ratings For Adamis Pharmaceuticals Corporation (ADMP)Share Trading NewsAdamis Pharmaceuticals Corporation has a 50 day moving average of 7.03 and a 200 day moving average of 5.34. The stock's market capitalization is 120.48M, it has a 52-week low of 3.05 and a 52-week high of 9.31. The share price of the company (ADMP) ...and more »
05/02/16 09:04 AMAdamis Pharmaceuticals Corporation (NASDAQ:ADMP) Comprehensive Income At $0 Millions For Quarter Closed ... - Stocks Daily - Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Comprehensive Income At $0 Millions For Quarter Closed ...Stocks DailyFor the year ended 2007-09-30, Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) comprehensive income was $0 millions whereas for the quarter ended 2007-09-30, the comprehensive income was $0 millions. Adamis Pharmaceuticals Corporation ...
05/02/16 09:04 AMBroker Roundup For Adamis Pharmaceuticals Corporation (ADMP) - Share Trading News - Broker Roundup For Adamis Pharmaceuticals Corporation (ADMP)Share Trading News06/24/2014 – Adamis Pharmaceuticals Corporation had its “positive” rating reiterated by analysts at CRT Capital. They now have a USD 15 price target on the stock. The share price of Adamis Pharmaceuticals Corporation (ADMP) was up +0.36% during the ...
04/29/16 09:14 AMAdamis Pharmaceuticals: Multi-Year Highs After Recent US Compounding Acquisition - ... Pharmaceuticals (NASDAQ:ADMP) announced an agreement to acquire US Compounding Inc (USC), a privately held compounding pharmacy based in Arkansas. As a long term follower and holder of the stock, I always thought Adamis would be the company acquired ...
04/27/16 10:13 AMUpgrades And Downgrades For Adamis Pharmaceuticals Corporation (ADMP) - Risers & Fallers - Upgrades And Downgrades For Adamis Pharmaceuticals Corporation (ADMP)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Adamis Pharmaceuticals Corporation (ADMP). The latest broker reports which are currently outstanding on Wednesday 27th of April state 0 analysts have a rating of “strong ...
04/22/16 09:40 AMAdamis Pharmaceuticals Corporation (ADMP) Updated Analyst Coverage - Risers & Fallers - Adamis Pharmaceuticals Corporation (ADMP) Updated Analyst CoverageRisers & FallersA number of investment brokers have recently updated their price targets on shares of Adamis Pharmaceuticals Corporation (ADMP). According to the latest broker reports outstanding on Friday 22nd of April, 0 analysts have a rating of “strong buy”, 0 ...
04/21/16 09:42 AMAdamis Pharmaceuticals Corporation (ADMP) Updated Broker Price Targets - Share Trading News - Web Breaking NewsAdamis Pharmaceuticals Corporation (ADMP) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Adamis Pharmaceuticals Corporation (ADMP). The latest reports which are currently in issue on Wednesday 20th of April state 0 analysts have a rating of “strong buy”, ...David J. Marguglio Sells 12000 Shares of Adamis Pharmaceuticals Corp (ADMP) StockWeb Breaking Newsall 2 news articles »
04/18/16 09:33 AM13D Filing: Eses Holdings and Adamis Pharmaceuticals Corp (ADMP) -
04/15/16 12:44 PMTrending Stocks: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), Marvell Technology Group Ltd. (NASDAQ ... - KC Register - Trending Stocks: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), Marvell Technology Group Ltd. (NASDAQ ...KC RegisterAdamis Pharmaceuticals Corporation (NASDAQ:ADMP) announced that it has successfully completed its previously announced acquisition of US Compounding, Inc. Upon the closing of this transaction, USC has become a wholly-owned subsidiary of Adamis.and more »
04/14/16 02:00 PMAdamis Pharmaceuticals Corporation (NASDAQ:ADMP) ABR At 1 - Investor Newswire - Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) ABR At 1Investor NewswireBrokerages maintain a strong outlook on Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) shares. Based on the Zacks poll results, as of 2016-04-13, the stock has an ABR of 1 rating. This number highlights the scoring on a 1 to 5 scale, where 1 implies ...and more »
03/29/16 12:04 PMADAMIS PHARMACEUTICALS CORP Financials -
01/29/16 03:15 PMADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Pr -
01/26/16 04:23 PMADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equi -
01/26/16 03:32 PMAdamis Pharmaceuticals Announces Private Placement - [at noodls] - , (GLOBE NEWSWIRE) -- (NASDAQ:ADMP) ('Company' or 'Adamis') announced today that it has completed a private placement financing transaction pursuant to which it issued 1,183,432 shares of Series A-1 Convertible ...
About Adamis Pharmaceuticals Corp

Adamis Pharmaceuticals Corp logoAdamis Pharmaceuticals Corporation is a pharmaceutical company. The Company is developing various products in the allergy and respiratory markets The Company's product portfolio includes specialty pharmaceutical products, such as Epinephrine pre-filled syringe (PFS), APC-5000 dry powder inhaler (DPI), APC-1000, APC-2000 and APC-3000, and biotechnology products, such as TeloB-VAX (vaccine), APC-100, APC-200 and APC-300. The Company's product candidates for the treatment of asthma and chronic obstructive pulmonary disease (COPD) are APC-5000 DPI and APC-1000. The Company's other product candidates in its allergy and respiratory product pipeline include APC-1000, APC-3000 and APC-2000. The Company's drug candidates for the treatment of prostate cancer are APC-100, APC-200 and APC-300. The Company also has a microbicide product candidate named Savvy (C31G). The Company's product candidate for the treatment of anaphylaxis is Epinephrine PFS.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drug Delivery
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ADMP
  • CUSIP:
Key Metrics:
  • Previous Close: $2.80
  • 50 Day Moving Average: $5.54
  • 200 Day Moving Average: $5.80
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $42.29M
  • Current Quarter EPS Consensus Estimate: $-0.89 EPS
Additional Links:
Adamis Pharmaceuticals Corp (NASDAQ:ADMP) Chart for Thursday, June, 30, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha